サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1739309

人工知能医療診断アプリの世界市場

Artificial Intelligence Medical Diagnosis App

出版日
ページ情報
英文 172 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.12円
人工知能医療診断アプリの世界市場
出版日: 2025年06月03日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 172 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

人工知能医療診断アプリの世界市場は2030年までに33億米ドルに達する

2024年に12億米ドルと推定される人工知能医療診断アプリの世界市場は、2024年から2030年にかけてCAGR 19.0％で成長し、2030年には33億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるクラウド導入は、CAGR 17.1％を記録し、分析期間終了時には21億米ドルに達すると予測されます。オンプレミスデプロイメントセグメントの成長率は、分析期間中CAGR 22.9%と推定されます。

米国市場は推定3億610万米ドル、中国はCAGR18.0％で成長予測

米国の人工知能医療診断アプリ市場は、2024年に3億610万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR18.0％を追いかけ、2030年までに5億1,040万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ17.2%と16.6%と予測されています。欧州では、ドイツがCAGR約14.2%で成長すると予測されています。

世界の人工知能医療診断アプリ市場- 主要動向と促進要因まとめ

なぜAIベースの医療診断アプリがデジタルヘルス変革の中心になりつつあるのか？

人工知能（AI）を搭載した医療診断アプリは、患者や臨床医に直接、迅速でアクセスしやすい、データ駆動型の事前診断を提供することで、進化するデジタルヘルスケアの展望に不可欠なものとなりつつあります。これらのアプリは、機械学習アルゴリズム、画像認識、自然言語処理（NLP）、予測分析を用いて、症状の評価、医療データの分析、確率的診断やトリアージ勧告の生成を行う。その有用性は、特にプライマリ・ケア、皮膚科、放射線科、眼科、慢性疾患管理において、病気の早期発見のためのタイムリーな洞察を提供し、不必要な臨床受診を減らし、遠隔診療をサポートすることにあります。

患者中心のケア、ヘルスケアの分散化、デジタルファーストの医療システムが世界的に重視されていることが、こうしたソリューションの採用を後押ししています。AI診断アプリは、ユーザーが症状を解釈し、ケア経路に優先順位をつけ、適切なヘルスケア・リソースにナビゲートするのを支援することで、効率を高める。ヘルスケアプロバイダーにとって、これらのツールは鑑別診断を支援し、文書化を自動化し、リスクの高い症例にフラグを立てることで、臨床上の意思決定と業務処理能力を向上させる。ヘルスケアコストの上昇と医師不足の中、AIを活用した診断アプリケーションは、最前線の医療サービスを拡張する費用対効果の高い拡張可能なものとして、ますます注目されています。

AIモデルと医療データエコシステムはどのように診断精度を高めているのか？

AIモデル開発と臨床データエコシステムとの統合の進歩により、医療診断アプリの精度と使いやすさが大幅に向上しています。電子カルテ（EHR）、画像アーカイブ、検査結果、患者報告データなど、匿名化された大規模なデータセットで訓練された教師あり学習アルゴリズムは、これらのアプリが疾患パターンを認識し、併存疾患を特定し、疾患固有のリスク評価を提供することを可能にします。自然言語処理（NLP）アルゴリズムは、フリーテキスト入力を解釈し、SNOMED CTやICD-10などの臨床オントロジーを使用して、可能性の高い状態を提案する症状チェッカーインターフェイスに電力を供給します。

ディープラーニングと畳み込みニューラルネットワーク（CNN）は、皮膚科の画像から皮膚がんを検出したり、網膜スキャンで糖尿病性網膜症を特定したり、胸部X線で肺炎や結核を分析したりするなど、視覚診断で特に大きな効果を発揮します。ウェアラブルデータやセンサーデータを統合して、不整脈検出、睡眠障害、呼吸器モニタリングなどの分野でリアルタイム診断を提供するアプリもあります。クラウドベースのプラットフォームは、新たな臨床エビデンスやユーザーフィードバックに基づくリアルタイムの更新やモデルの再トレーニングを可能にし、アプリの適応性を高めています。データの相互運用性と連携学習が成熟するにつれて、これらのアプリはより正確で説明しやすくなり、臨床検証基準に準拠するようになっています。

市場の需要はどこで加速し、どの使用事例が採用をリードしているか？

AIベースの医療診断アプリに対する市場需要は、先進国市場と新興国市場の両方で急速に拡大しており、米国、欧州、アジア太平洋地域で大きな牽引力となっています。北米では、遠隔医療との統合、スマートフォンの普及率の高さ、デジタル治療薬やAIを活用した臨床ツールに対する規制の機運の高さなどが普及の原動力となっています。欧州では、デジタルヘルス改革と国営医療システムの普及により、AI診断アプリを公的ヘルスケアのワークフローに組み込むことが可能になっています。一方、アジア太平洋では、モバイルの利用率が高いこと、農村部では医療専門家へのアクセスが限られていること、政府主導のデジタルヘルスイニシアチブがあることから、急速に導入が進んでいます。

主な使用事例としては、自己診断のための症状チェックアプリ、コールセンターやチャットボットで使用されるAI搭載のトリアージアシスタント、皮膚科画像解析アプリ、眼科スクリーニングアプリ、放射線科事前スクリーニングツールなどがあります。特に糖尿病、高血圧、喘息などの慢性疾患管理アプリも、生体情報を解釈してリアルタイムの介入を提案するためにAIを組み込んでいます。音声や表情分析に基づくメンタルヘルス診断は、新たなフロンティアです。企業での利用も拡大しており、保険会社や病院ネットワークがAIアプリを導入することで、保険金不正請求の削減、ペイシェントジャーニーの最適化、遠隔患者モニタリング・プログラムにおける早期警告サインのフラグ立てなどが行われています。

AI医療診断アプリの世界的成長の原動力は？

AI医療診断アプリ市場の成長は、オンデマンドの健康情報に対する消費者の需要の高まり、慢性疾患の有病率の増加、AI、モバイルコンピューティング、医療画像の技術的進歩など、いくつかの重要な要因によって牽引されています。重要な推進力は、デジタルヘルスプラットフォームの融合、患者のエンパワーメント動向、都市部と未開拓地域の両方における診断ギャップを埋めるためのスケーラブルなソリューションの必要性です。COVID-19は、遠隔診断がトリアージ、検査、フォローアップに不可欠なツールであることを実証し、普及をさらに加速させました。

ベンチャー企業の資金調達、医療技術アクセラレーター、AI新興企業、医療技術企業、ヘルスケアプロバイダー間の戦略的パートナーシップは、急速なイノベーションと商業化に拍車をかけています。FDAやCEなどの規制機関は、臨床グレードのAIアプリ承認のための明確な枠組みを提供するようになってきており、HIPAA/GDPRに準拠したアーキテクチャはプライバシーと信頼の障壁に対処しています。EHRとの統合、遠隔医療プラットフォーム用API、多言語インターフェースは、これらのアプリをより使いやすく、文脈を認識できるものにしています。AI診断ツールが症状チェッカーから症状別診断アシスタントへと進化するにつれ、重要な疑問が生じます。人工知能を搭載した診断アプリは、安全かつ公平で、臨床的に検証されたソリューションを提供できるのでしょうか？

セグメント

デプロイメント（クラウド、オンプレミス）;アプリケーション（放射線学、病理学、循環器学、皮膚科学、その他のアプリケーション）;エンドユーザー（病院、診断センター、クリニック、その他のエンドユーザー）

調査対象企業の例（注目の36社）

  • Ada Health
  • AI Medical Service
  • AIDoc
  • AliveCor
  • Arterys
  • Babylon Health
  • Bay Labs
  • Binah.ai
  • Buoy Health
  • Butterfly Network
  • Caption Health
  • Corti
  • Eko Health
  • Enlitic
  • GE Healthcare
  • Google Health
  • IBM Watson Health
  • iCAD
  • Infermedica
  • Lunit

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP33466

Global Artificial Intelligence Medical Diagnosis App Market to Reach US$3.3 Billion by 2030

The global market for Artificial Intelligence Medical Diagnosis App estimated at US$1.2 Billion in the year 2024, is expected to reach US$3.3 Billion by 2030, growing at a CAGR of 19.0% over the analysis period 2024-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the On-Premise Deployment segment is estimated at 22.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$306.1 Million While China is Forecast to Grow at 18.0% CAGR

The Artificial Intelligence Medical Diagnosis App market in the U.S. is estimated at US$306.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$510.4 Million by the year 2030 trailing a CAGR of 18.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.2% and 16.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.2% CAGR.

Global Artificial Intelligence Medical Diagnosis App Market - Key Trends & Drivers Summarized

Why Are AI-Based Medical Diagnosis Apps Becoming Central to Digital Health Transformation?

Artificial Intelligence (AI)-powered medical diagnosis apps are becoming integral to the evolving landscape of digital healthcare by delivering rapid, accessible, and data-driven preliminary diagnostics directly to patients and clinicians. These apps use machine learning algorithms, image recognition, natural language processing (NLP), and predictive analytics to assess symptoms, analyze medical data, and generate probabilistic diagnoses or triage recommendations. Their utility lies in offering timely insights for early disease detection, reducing unnecessary clinical visits, and supporting remote care delivery-especially in primary care, dermatology, radiology, ophthalmology, and chronic disease management.

The global emphasis on patient-centered care, healthcare decentralization, and digital-first medical systems is propelling adoption of these solutions. AI diagnostic apps enhance efficiency by helping users interpret symptoms, prioritize care pathways, and navigate to appropriate healthcare resources. For healthcare providers, these tools assist in differential diagnosis, automate documentation, and flag high-risk cases, thereby improving clinical decision-making and operational throughput. Amid rising healthcare costs and physician shortages, AI-powered diagnostic applications are increasingly viewed as cost-effective, scalable extensions of frontline medical services.

How Are AI Models and Medical Data Ecosystems Enhancing Diagnostic Precision?

Advancements in AI model development and integration with clinical data ecosystems are significantly improving the accuracy and usability of medical diagnosis apps. Supervised learning algorithms trained on large, anonymized datasets-from electronic health records (EHRs), imaging archives, lab results, and patient-reported data-enable these apps to recognize disease patterns, identify comorbidities, and offer condition-specific risk assessments. Natural language processing (NLP) algorithms power symptom-checker interfaces that interpret free-text input and suggest likely conditions using clinical ontologies such as SNOMED CT and ICD-10.

Deep learning and convolutional neural networks (CNNs) are especially impactful in visual diagnostics-such as detecting skin cancer from dermatology images, identifying diabetic retinopathy in retinal scans, or analyzing chest X-rays for pneumonia or tuberculosis. Some apps integrate wearable and sensor data to provide real-time diagnostics in areas like arrhythmia detection, sleep disorders, and respiratory monitoring. Cloud-based platforms are enabling real-time updates and model retraining based on new clinical evidence and user feedback, enhancing app adaptability. As data interoperability and federated learning mature, these apps are becoming more accurate, explainable, and compliant with clinical validation standards.

Where Is Market Demand Accelerating and Which Use Cases Are Leading Adoption?

Market demand for AI-based medical diagnosis apps is growing rapidly in both developed and emerging markets, with significant traction in the U.S., Europe, and Asia-Pacific. In North America, adoption is driven by telemedicine integration, high smartphone penetration, and favorable regulatory momentum toward digital therapeutics and AI-enabled clinical tools. In Europe, digital health reforms and widespread use of national health systems are enabling integration of AI diagnostic apps into public healthcare workflows. Meanwhile, Asia-Pacific is seeing fast adoption due to high mobile usage, limited access to healthcare professionals in rural areas, and government-led digital health initiatives.

Leading use cases include symptom-checker apps for self-assessment, AI-powered triage assistants used in call centers or chatbots, dermatology image analyzers, ophthalmic screening apps, and radiology pre-screening tools. Chronic condition management apps, especially for diabetes, hypertension, and asthma, are also incorporating AI to interpret biometrics and suggest real-time interventions. Mental health diagnostics based on speech and facial expression analytics are an emerging frontier. Enterprise use is also growing, with insurers and hospital networks deploying AI apps to reduce claims fraud, optimize patient journeys, and flag early warning signs in remote patient monitoring programs.

What Is Driving the Global Growth of AI Medical Diagnosis Apps?

The growth in the AI medical diagnosis app market is driven by several key factors, including rising consumer demand for on-demand health information, increasing chronic disease prevalence, and technological advancements in AI, mobile computing, and medical imaging. A critical driver is the convergence of digital health platforms, patient empowerment trends, and the need for scalable solutions to bridge diagnostic gaps in both urban and underserved regions. COVID-19 further accelerated adoption by validating remote diagnostics as essential tools for triaging, testing, and follow-up.

Venture funding, healthtech accelerators, and strategic partnerships between AI startups, medtech firms, and healthcare providers are fueling rapid innovation and commercialization. Regulatory bodies like the FDA and CE are increasingly providing clear frameworks for clinical-grade AI app approval, while HIPAA/GDPR-compliant architectures are addressing privacy and trust barriers. Integration with EHRs, APIs for telehealth platforms, and multilingual interfaces are making these apps more usable and context-aware. As AI diagnostic tools evolve from symptom checkers to condition-specific diagnostic assistants, a key question arises: Can artificial intelligence-powered diagnosis apps deliver safe, equitable, and clinically validated solutions that extend diagnostic intelligence beyond the clinic and into the hands of every user?

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence Medical Diagnosis App market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Deployment (Cloud, On-Premise); Application (Radiology, Pathology, Cardiology, Dermatology, Other Applications); End-User (Hospitals, Diagnostic Centers, Clinics, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • Ada Health
  • AI Medical Service
  • AIDoc
  • AliveCor
  • Arterys
  • Babylon Health
  • Bay Labs
  • Binah.ai
  • Buoy Health
  • Butterfly Network
  • Caption Health
  • Corti
  • Eko Health
  • Enlitic
  • GE Healthcare
  • Google Health
  • IBM Watson Health
  • iCAD
  • Infermedica
  • Lunit

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Artificial Intelligence Medical Diagnosis App - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Smartphone-Based AI Medical Diagnosis Apps Democratize Access to Early Health Screening
    • Clinical-Grade Algorithms Drive Accuracy of AI Medical Diagnosis Apps in Real-World Settings
    • AI-Powered Apps Expand Telehealth Capabilities With Instant Diagnostic Support
    • Symptom Checkers Integrated With AI Apps Enhance Patient Triage and Navigation
    • Remote Monitoring Features Embedded in AI Diagnosis Apps Improve Chronic Disease Management
    • Regulatory Validation and CE/FDA Approvals Boost Trust in AI-Powered Diagnosis Apps
    • Multi-Language and Voice Recognition Features Improve AI App Accessibility in Diverse Populations
    • Behavioral Health and Dermatology Emerge as Key Focus Areas for AI Medical Diagnosis Apps
    • Real-Time Feedback and Learning Loops Enhance Diagnostic Precision in AI Health Apps
    • Wearable Sync Capabilities Augment Data Streams for AI Diagnosis Applications
    • Consumer Health Ecosystems Evolve Around AI Medical Apps for Proactive Wellness Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence Medical Diagnosis App Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Radiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Pathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Dermatology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030

IV. COMPETITION